Zobrazeno 1 - 10
of 267
pro vyhledávání: '"Hertzel, Gerstein"'
Autor:
Roman Jaeschke, Hertzel C. Gerstein
Publikováno v:
Polish Archives of Internal Medicine. 126:803-805
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::186b02527a8b2692bea6b53f5dca5121
https://doi.org/10.20452/pamw.3612
https://doi.org/10.20452/pamw.3612
Autor:
Gerstein H, Jaeschke R
Publikováno v:
Polskie Archiwum Medycyny Wewnetrznej [Pol Arch Med Wewn] 2016 Nov 30; Vol. 126 (11), pp. 907-908. Date of Electronic Publication: 2016 Nov 30.
Autor:
Gerstein H, Jaeschke R
Publikováno v:
Polskie Archiwum Medycyny Wewnetrznej [Pol Arch Med Wewn] 2016 Oct 28; Vol. 126 (10), pp. 803-805. Date of Electronic Publication: 2016 Oct 28.
Autor:
Hertzel C. Gerstein, Roman Jaeschke
Publikováno v:
Polish Archives of Internal Medicine. 126:907-908
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::991cf6ab052304b723976cd45468c687
https://doi.org/10.20452/pamw.3663
https://doi.org/10.20452/pamw.3663
Autor:
Arjun K. Pandey, Iva Okaj, Hargun Kaur, Emilie P. Belley‐Cote, Jia Wang, Alireza Oraii, Alexander P. Benz, Linda S. B. Johnson, Jack Young, Jorge A. Wong, Subodh Verma, David Conen, Hertzel Gerstein, Jeff S. Healey, William F. McIntyre
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 17 (2021)
Background Sodium‐glucose co‐transporter (SGLT) inhibitors reduce cardiovascular outcomes including mortality in several populations; however, their effect on atrial fibrillation/flutter (AF) remains unclear. Our objective was to determine whethe
Externí odkaz:
https://doaj.org/article/6ee90f54d9d149abb49b6adeff519b11
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 3 (2020)
Background Frailty is associated with higher mortality in individuals at high cardiovascular disease (CVD) risk. We hypothesize that frailty is a more important prognostic factor than CVD risk factors and aim to determine the prognostic value of a cu
Externí odkaz:
https://doaj.org/article/873d1114bda6432288646e3d75082147
Autor:
Janet Wittes, Thomas Fleming, David DeMets, Susan Ellenberg, Hertzel Gerstein, Marc Pfeffer, Frank Rockhold, Salim Yusuf, Charles Hennekens
Publikováno v:
Therapeutic Innovation & Regulatory Science.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33352dc3dd83e526c7de7c70e4f8c5da
https://doi.org/10.1007/s43441-023-00520-6
https://doi.org/10.1007/s43441-023-00520-6
Autor:
Rosa Pando, Nazarii Kobyliak, Milica Marjanovic Petkovic, Ángel Michael Ortiz Zúñiga, Kevser Onbasi, Hans Prozesky, Neslihan Bascil Tutuncu, Tomasz Skowerski, Kelley Branch, Vladimir Rafalskiy, Fernando Lanas, Dedrick Jordan, Felix Jebasingh, Türkan Paşalı Kilit, Hertzel Gerstein, Miljanka Vuksanovic, Aleksandar Djukic
Publikováno v:
New England Journal of Medicine. 385:896-907
Background: \ud Four glucagon-like peptide-1 (GLP-1) receptor agonists that are structurally similar to human GLP-1 have been shown to reduce the risk of adverse cardiovascular events among persons with type 2 diabetes. The effect of an exendin-based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc499997c570e1c5c5b9b0d99de90b5b
https://doi.org/10.1056/nejmoa2108269
https://doi.org/10.1056/nejmoa2108269
Autor:
Wei-She Julia Tai, Richa Parihar, Mary Ellene Boulos, Hertzel Gerstein, Meera Luthra, Ahraaz Wyne
Publikováno v:
Annals of Internal Medicine: Clinical Cases. 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::258d676821c255ca018429b517e9bdc2
https://doi.org/10.7326/aimcc.2021.0238
https://doi.org/10.7326/aimcc.2021.0238
Publikováno v:
Canadian Journal of Diabetes. 47:243-249.e2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73409562dd66416f7cb87fe555b6a467
https://doi.org/10.1016/j.jcjd.2023.01.001
https://doi.org/10.1016/j.jcjd.2023.01.001